The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Thermo Fisher Scientific Inc

NYSE: TMO
Last

(U.S.) $158.98

Today's change+0.25 +0.16%
Updated February 24 4:00 PM EST. Delayed by at least 15 minutes.
 

Thermo Fisher Scientific Inc

NYSE: TMO
Last

(U.S.) $158.98

Today's change+0.25 +0.16%
Updated February 24 4:00 PM EST. Delayed by at least 15 minutes.

Thermo Fisher Scientific Inc up (U.S.)$0.25

Thermo Fisher Scientific Inc closed up Friday by (U.S.)$0.25 or 0.16% to (U.S.)$158.98. Over the last five days, shares are unchanged, but are currently 1.05% below its 52-week high. This security has performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $158.34
  • Previous close(U.S.) $158.73
  • High(U.S.) $158.98
  • Low(U.S.) $157.58
  • Bid / Ask-- / --
  • YTD % change+12.67%
  • Volume832,828
  • Average volume (10-day)1,310,996
  • Average volume (1-month)1,918,883
  • Average volume (3-month)1,974,239
  • 52-week range(U.S.) $127.65 to (U.S.) $160.68
  • Beta1.09
  • Trailing P/E31.19×
  • P/E 1 year forward17.36×
  • Forward PEG1.64×
  • Indicated annual dividend(U.S.) $0.60
  • Dividend yield0.38%
  • Trailing EPS(U.S.) $5.10
Updated February 24 4:00 PM EST. Delayed by at least 15 minutes.
S&P TSX1.57%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Oct 01, 201610/01/2016Jul 02, 201607/02/2016Apr 02, 201604/02/2016
Revenue4,9534,4914,5354,295
Total other revenue--------
Total revenue4,9534,4914,5354,295
Gross profit2,4072,0542,0791,958
Total cost of revenue2,5472,4372,4572,337
Total operating expense4,2013,9503,8983,777
Selling / general / administrative1,0171,2121,2191,184
Research & development213183182177
Depreciation / amortization376------
Interest expense (income), net operating--------
Unusual expense (income)481173980
Other operating expenses, total--------
Operating income753541638518
Interest income (expense), net non-operating-131-113-119-106
Gain (loss) on sale of assets--------
Other--------
Income before tax652428521423
Income after tax633474517402
Income tax, total19-46421
Net income630474517402
Total adjustments to net income--------
Net income before extra. items633474517402
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items633474517402
Inc. avail. to common incl. extra. items630474517402
Diluted net income630474517402
Dilution adjustment--------
Diluted weighted average shares397397397399
Diluted EPS excluding extraordinary itemsvalue per share1.591.191.301.01
Dividends per sharevalue per share0.150.150.150.15
Diluted normalized EPSvalue per share1.711.381.401.20